论文部分内容阅读
乳腺小叶原位癌,英文名称:lobular carcinoma in situ,简称:LCIS,是位于乳腺上皮细胞的一种非侵润性乳腺癌。1919年出版的《肿癌性疾病》中就对此病特点和原理进行详细描述,但未有确切名称。1941年Ste-wart和Foote首次运用乳腺小叶原位癌这一名称。LCIS在临床上不是特别常见,几年来乳腺癌大规模普查,其检出率逐渐提高。本文从乳腺小叶原位癌发病情况出发,对临床特点予以分析,并对外科治疗进展情况进行研究。
Breast lobular carcinoma in situ, English name: Lobular carcinoma in situ, referred to as: LCIS, is located in the breast epithelial cells of a non-invasive breast cancer. The characteristics and principles of this disease are described in detail in “Carcinogenic Diseases of Cancers” published in 1919, but no exact name is given. 1941 Ste-wart and Foote for the first time using the name of breast lobular carcinoma in situ. LCIS is not particularly common clinically, breast cancer large-scale census in recent years, the detection rate gradually increased. In this paper, starting from the incidence of breast lobular carcinoma in situ, the clinical features to be analyzed, and the progress of surgical treatment were studied.